Obesity: Next Medicines with Impact
February 10, 2025
GLP-1 analogs have changed the game for many people living with obesity, but the medical community is looking for improvements in delivery, side effect profiles and more. This panel will examine how innovators pursuing obesity are hoping to magnify the positive impact of GLP-1 analogs while minimizing the side effects that negatively impact the patient experience. In addition, the session will explore what investors are looking for as they prioritize their capital deployment.
Speakers
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}